Jason Napadano on Twitter now says approval is a "long shot"
About an hour ago, when asked on Twitter if he thought it would be approved or not, he responded "After reading this docs, I'd say it's a long-shot". Pretty disapointing since he has been an advocate for the company for some time and has repeatedly stated that the clinical data was "impressive" Interestingly, Adam F. seems more upbeat saying it could still get the ok by committee. The fact that Jason N would say this just shows that you can't put much faith in what any "analyst" says either positive or negative about a stock and need to follow your own due diligence.
How these analysts respond to the BD is immaterial. The result will be in the hands of the ADCOM members. Is the outcome is totally based on FDA's comments, we won't need the ADCOM. BTW, I don't even think the BD is that bad at all. I am holding all my shares and will add more if the slide continues tomorrow due to the negativity.